Forescout Technologies, Inc. has entered into a strategic partnership with Medigate, a dedicated medical device security and asset management solution, to help healthcare organisations continuously discover, identify, assess and secure all Internet of Medical Things (IoMT), IoT, operational technology (OT) and IT network connected devices. Through this new collaboration, the companies have developed an integration to bring together Medigate’s in-depth IoMT visibility, anomaly detection and lifecycle management capabilities with Forescout’s enterprise device visibility, automated segmentation and incident response capabilities. Forescout will also resell the Medigate Platform.
“Connected medical devices represent a fast-growing threat attack vector and the lack of device manufacturer standardisation and interoperability has created a significant problem for clinical care network operations,” said Pedro Abreu, chief product and strategy officer, Forescout. “The combination of Medigate’s deep knowledge of medical devices and the healthcare industry with Forescout’s breadth of device intelligence adds a new level of cohesive device insight, expertise and security for the healthcare industry.”
Medigate enables IT, info security, biomedical and clinical engineering teams to identify, monitor and secure every medical device on the clinical network. Utilising Medigate’s context-rich medical device classification and information, Forescout will enforce granular access control, segmentation and other compliance policies for clinical networks. Forescout will also extend these capabilities across all other connected devices in the health delivery organisation for a cohesive, centralised device visibility and control platform.
The joint offering will utilise passive technologies to identify and classify all connected medical devices and IT assets on health delivery organisation networks, including unknown and hard-to-classify devices, while minimising disruption. It will provide valuable insights to support corporate security policies to protect biomedical devices through effective vulnerability management, anomaly and threat detection and risk scoring. Through this partnership, customers will be able to design and implement effective segmentation and control access to the clinical network.
“The Medigate and Forescout partnership and integration provide healthcare organisations with rich contextual visibility into their IT and clinical networks, as well as sophisticated network analysis to detect threats and implement clinically-driven policies,” said Jonathan Langer, co-founder and CEO, Medigate. “These actionable insights will, in turn, reduce risk and improve patient safety.”
